Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 121Breast Neoplasms 83Colorectal Neoplasms 52Stomach Neoplasms 42Pancreatic Neoplasms 42Lung Neoplasms 41Rectal Neoplasms 38Neoplasm Metastasis 36Neoplasms 33Esophageal Squamous Cell Carcinoma 32Esophageal Neoplasms 31Head and Neck Neoplasms 26Squamous Cell Carcinoma of Head and Neck 23Ovarian Neoplasms 23Triple Negative Breast Neoplasms 21Nasopharyngeal Carcinoma 20Recurrence 18Leukemia, Myeloid, Acute 18Colonic Neoplasms 18Uterine Cervical Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Small Cell Lung Carcinoma 15Glioblastoma 15Lymphoma 12Prostatic Neoplasms 11Fallopian Tube Neoplasms 11Carcinoma, Squamous Cell 11Brain Neoplasms 11Sarcoma 10NSCLC 9

Interventions

Etoposide 2Carboplatin 2tremelimumab 1etoposide phosphate 1durvalumab 1Photochemotherapy 1Paclitaxel 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Drug Therapy 1Dihematoporphyrin Ether 1Cyclophosphamide 1Cisplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Germinoma × Drug Therapy × Clear all
NCT06418789 2025-08-03

GERMAN

N.N. Petrov National Medical Research Center of Oncology

Phase 2 Recruiting
25 enrolled

Nonseminomatous germ cell tumor, Choriocarcinoma, Neoplasms, Germ Cell and Embryonal, Teratoma, Germinoma, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡